MiNK Therapeutics, Inc.

NASDAQ:INKT

7.25 (USD) • At close April 17, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -10,784.802-22.458-27.991-30.213-16.239-23.802
Depreciation & Amortization 0.2150.2050.1220.0780.0550.037
Deferred Income Tax 000-0.35600
Stock Based Compensation 1,810.2263.863.0271.7450.0880.22
Change In Working Capital 0.462.8978.7673.736-0.3254.115
Accounts Receivables 00001.8023.433
Inventory 0000-1.802-3.433
Accounts Payables -1.182-1.9182.661-0.1520.6080.887
Other Working Capital 1.6424.8156.1063.888-0.9333.229
Other Non Cash Items -581.575-0.267-2.79112.1828.0834.486
Operating Cash Flow -9,555.476-15.763-18.867-12.827-8.338-14.944
Investing Activities:
Investments In Property Plant And Equipment 0-0.074-0.25-0.249-0.095-0.426
Acquisitions Net 000000
Purchases Of Investments 000000
Sales Maturities Of Investments 000000
Other Investing Activites 00-250.046-248.98300
Investing Cash Flow 0-0.074-0.25-0.249-0.095-0.426
Financing Activities:
Debt Repayment 5009.45911.10511.436
Common Stock Issued 5.80039.7970.0010
Common Stock Repurchased 0-0.478-0.157000
Dividends Paid 000000
Other Financing Activities 10,809.1860.070.002000
Financing Cash Flow 10,819.986-0.407-0.15649.25711.10611.436
Other Information:
Effect Of Forex Changes On Cash -54.699-0.0250.0190.017-0.281-0.122
Net Change In Cash 1,209.811-16.268-19.25336.1982.392-4.057
Cash At End Of Period 4,577.043.36719.63638.8892.6910.299